Anatara Lifesciences Ltd (ASX:ANR) Presents at Australasian Pig Science Association Conference

(MENAFN- ABN Newswire) A Comparative Study of the Efficacy of Detach(R) Versus Zinc Oxide to Control Post-Weaning Diarrhoea in PigletsSydney, Nov 21, 2017 AEST (ABN Newswire) - At the Australasian Pig Science Association (APSA) Conference in Melbourne this week, Dr Trish Holyoake & Dr Tracey Mynott presented a poster highlighting the comparable efficacy of a single dose of Anatara's () Detach(R) product to in-feed Zinc oxide (ZnO) in reducing diarrhoea and antibiotic treatments in post-weaning piglets. These results are significant given the push to remove ZnO from the food chain.

INTRODUCTION

Anatara Lifesciences is currently applying for re-registration of Detach(R) as an alternative to antibiotics and Zinc Oxide (ZnO) to aid in the control of pre- and post-weaning diarrhoea in piglets. Bromelain, the active in Detach(R) reduces diarrhoea through its anti-attachment and anti-secretory effect (see Notes 1, 2 below) on the intestine, and is therefore unlikely to contribute to antimicrobial resistance. This study was designed to compare the efficacy of a single 4mL Detach(R) drench at weaning (18-28 days of age) to ZnO (2,500 ppm in feed) as an aid in the control of post-weaning diarrhoea in piglets.

CONCLUSION

A single dose of Detach(R) at weaning was as effective as in-feed ZnO in reducing diarrhoea and antibiotic treatments in piglets post-weaning compared to untreated piglets.

Notes:

Literature Cited:

1 Chandler DS, Mynott TL (1998) Gut 43, 196-202;

2 Mynott TL, Guandalini S, Raimondi F, Fasano A (1997) Gastroenterology 113, 175-184

To view tables and figures, please visit:



About Anatara Lifesciences Ltd

() is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called 'super bugs that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies. Please see for further background.

MENAFN2111201701110000ID1096119168